113 related articles for article (PubMed ID: 31409216)
1. Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients.
Inoue M; Kusumoto H; Shiono H; Shintani Y; Ose N; Sakamaki Y; Okami J; Higashiyama M; Takeuchi Y
J Chemother; 2019 Oct; 31(6):343-348. PubMed ID: 31409216
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.
Okumura N; Sonobe M; Okabe K; Nakamura H; Kataoka M; Yamashita M; Nakata M; Kataoka K; Yamashita Y; Soh J; Yoshioka H; Hotta K; Matsuo K; Sakamoto J; Toyooka S; Date H
Int J Clin Oncol; 2017 Apr; 22(2):274-282. PubMed ID: 27921177
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.
Tanaka H; Tabe C; Okumura F; Shiratori T; Ishioka Y; Itoga M; Taima K; Morimoto T; Kimura D; Tsushima T; Tasaka S
Thorac Cancer; 2020 Jun; 11(6):1633-1638. PubMed ID: 32351044
[TBL] [Abstract][Full Text] [Related]
4. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y
Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872
[TBL] [Abstract][Full Text] [Related]
5. Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.
Soh J; Okumura N; Nakata M; Nakamura H; Fukuda M; Kataoka M; Kajiwara S; Sano Y; Aoe M; Kataoka K; Hotta K; Matsuo K; Toyooka S; Date H
Jpn J Clin Oncol; 2016 Aug; 46(8):741-7. PubMed ID: 27207886
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.
Komazaki Y; Sakashita H; Furuiye M; Fujie T; Tamaoka M; Sumi Y; Miyazaki Y; Kojima K; Jin Y; Inase N
Chemotherapy; 2013; 59(1):35-41. PubMed ID: 23816760
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
Okumura N; Soh J; Suzuki H; Nakata M; Fujiwara T; Nakamura H; Sonobe M; Fujinaga T; Kataoka K; Gemba K; Kataoka M; Hotta K; Yoshioka H; Matsuo K; Sakamoto J; Date H; Toyooka S
BMC Cancer; 2021 May; 21(1):506. PubMed ID: 33957881
[TBL] [Abstract][Full Text] [Related]
8. Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial.
Hata Y; Kiribayashi T; Kishi K; Nagashima M; Nakayama T; Ikeda S; Kadokura M; Ozeki Y; Otsuka H; Murakami Y; Takagi K; Iyoda A
BMC Cancer; 2017 Aug; 17(1):581. PubMed ID: 28851314
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.
Sekine A; Satoh H; Baba T; Ikeda S; Okuda R; Shinohara T; Komatsu S; Hagiwara E; Iwasawa T; Ogura T; Kato T
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1245-52. PubMed ID: 27130459
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations.
Tamiya A; Tamiya M; Shiroyama T; Saijo N; Nakatani T; Minomo S; Tsuji T; Takeuchi N; Omachi N; Kurata K; Suzuki H; Okamoto N; Okishio K; Hirashima T; Atagi S
Med Oncol; 2015 Mar; 32(3):40. PubMed ID: 25616723
[TBL] [Abstract][Full Text] [Related]
11. Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Imai H; Utsugi M; Iwasaki Y; Shimizu K; Iijima H; Tsurumaki H; Tomizawa Y; Hisada T; Ishizuka T; Saito R; Mori M
Lung Cancer; 2010 May; 68(2):253-7. PubMed ID: 19631403
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S-1 in patients with stage II-IIIA non-small cell lung cancer.
Tsuboi M; Kondo K; Takizawa H; Kawakita N; Sawada T; Toba H; Kawakami Y; Yoshida M; Ishikura H; Kimura S; Tangoku A
J Med Invest; 2018; 65(1.2):90-95. PubMed ID: 29593202
[TBL] [Abstract][Full Text] [Related]
13. Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809.
Niho S; Ikeda N; Michimae H; Suzuki K; Sakai H; Kaburagi T; Minato K; Kato T; Okamoto H; Seto T; Hosomi Y; Shimizu K; Oshita F; Kunitoh H; Tsuboi M; Takeuchi M; Watanabe K
Br J Cancer; 2013 Aug; 109(3):545-51. PubMed ID: 23868010
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202.
Kuyama S; Ochi N; Bessho A; Hotta K; Ikeda G; Kishino D; Kubo T; Harada D; Fujimoto N; Nakanishi M; Umeno T; Okada T; Chikamori K; Yamagishi T; Ohashi K; Ichihara E; Takigawa N; Tanimoto M; Kiura K
Lung Cancer; 2017 Oct; 112():188-194. PubMed ID: 29191594
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer.
Yamashita Y; Kataoka K; Ishida T; Matsuura M; Seno N; Mukaida H; Miyahara E; Miyata Y; Okita R; Shimizu K; Watari M; Okumichi T; Okada M
J Thorac Oncol; 2008 Jun; 3(6):612-6. PubMed ID: 18520800
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study.
Tsuchiya T; Matsumoto K; Miyazaki T; Doi R; Tokunaga S; Yamaguchi H; Tomoshige K; Watanabe H; Nagayasu T; Sugio K
BMC Cancer; 2021 Mar; 21(1):249. PubMed ID: 33685421
[TBL] [Abstract][Full Text] [Related]
17. Feasibility study of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected non-small-cell lung cancer: FAST-nab.
Saji H; Marushima H; Miyazawa T; Sakai H; Kimura H; Kurimoto N; Nakamura H
Anticancer Drugs; 2017 Aug; 28(7):795-800. PubMed ID: 28538017
[TBL] [Abstract][Full Text] [Related]
18. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
[TBL] [Abstract][Full Text] [Related]
19. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer.
Schmid-Bindert G; Engel-Riedel W; Reck M; Schuette W; Stöhlmacher J; Fischer JR; Mazières J; Chouaid C; Wolf M; Vinolas N; Soldatenkova V; Ripoche V; Nguyen T; Visseren-Grul C
Lung Cancer; 2015 Dec; 90(3):397-404. PubMed ID: 26791798
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.
Niho S; Hosomi Y; Okamoto H; Nihei K; Tanaka H; Hida T; Umemura S; Goto K; Akimoto T; Ohe Y
Jpn J Clin Oncol; 2019 Jul; 49(7):614-619. PubMed ID: 30916304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
